Deals this week: Valeant Pharmaceuticals International, ImmunoPrecise Antibodies
Valeant Pharmaceuticals International has announced the sale of its subsidiary Dendreon Pharmaceuticals for $819.9m to Sanpower Group.
The divestiture is part of the Canadian company’s plans to simplify its business and reduce debt.
ImmunoPrecise Antibodies has announced the private placement of four million shares priced at C$1 ($0.77) each to raise C$4m ($3.08m).
ImmunoPrecise is a Canadian-based provider of antibodies that plans to use the funds to acquire U-Protein Express.